Sanj K Patel Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sanj K Patel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sanj K Patel. Sanj K Patel is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and President & CEO in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Chairman & CEO in Kiniksa Pharmaceuticals, Ltd. ($KNSA).

Latest Insider Trading Transactions of Sanj K Patel

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BCRX, KNSA, GEVA, SYRS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 23 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA0.0012,002012,002
Mar 23 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA0.0018,555018,555
Mar 18 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA0.0026,276026,276
Mar 18 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA22.89157,6583,608,792157,658
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseM1.591,6002,544325,271
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseM1.5920,40132,438326,871
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseM1.594,9247,829347,272
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS23.071,13726,23183,33684.5 K to 83.3 K (-1.35 %)
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS23.061,60036,89601.6 K to 0 (-100.00 %)
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOBuyM1.591,6002,5441,6000 to 1.6 K
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS23.0823,569543,97384,473108 K to 84.5 K (-21.81 %)
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS23.004,528104,144108,042112.6 K to 108 K (-4.02 %)
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS23.0420,401470,039020.4 K to 0 (-100.00 %)
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOBuyM1.5920,40132,43820,4010 to 20.4 K
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS23.004,924113,25204.9 K to 0 (-100.00 %)
Feb 10 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOBuyM1.594,9247,8294,9240 to 4.9 K
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseM1.59150,700239,613352,196
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseM1.598721,386502,896
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS21.0299,3302,087,917112,570211.9 K to 112.6 K (-46.88 %)
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS21.02150,7003,167,7140150.7 K to 0 (-100.00 %)
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOBuyM1.59150,700239,613150,7000 to 150.7 K
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS21.0067014,070211,900212.6 K to 211.9 K (-0.32 %)
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS21.0087218,3120872 to 0 (-100.00 %)
Oct 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOBuyM1.598721,3868720 to 872
Sep 14 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA15.50180,0002,790,000180,000
Mar 17 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA15.52180,0002,793,600180,000
Mar 10 2020KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOSellS20.0033,115662,300212,570245.7 K to 212.6 K (-13.48 %)
Sep 19 2019KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA8.83190,0001,677,700190,000
Mar 06 2019KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA17.92187,0003,351,040187,000
Sep 24 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA30.93125,0003,866,250125,000
May 29 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseC0.00428,20301,526,160
May 29 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseC0.0063,92200
May 29 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseC0.0071,96700
May 29 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseC0.00428,20300
May 29 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseP0.0063,922063,922
May 29 2018KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOBuyC0.00135,8890245,685109.8 K to 245.7 K (+123.76 %)
Jun 12 2017SYRSSyros Pharmaceutic ...Patel Sanj KDirectorOption ExerciseA14.2611,000156,86011,000
May 25 2017BCRXBIOCRYST PHARMACEU ...Patel Sanj KDirectorOption ExerciseA5.1330,000153,90030,000
Sep 19 2016SYRSSyros Pharmaceutic ...Patel Sanj KDirectorOption ExerciseA12.5922,000276,98022,000
May 25 2016BCRXBIOCRYST PHARMACEU ...Patel Sanj KDirectorOption ExerciseA3.2230,00096,60030,000
Sep 29 2015BCRXBIOCRYST PHARMACEU ...Patel Sanj KDirectorOption ExerciseA11.1816,667186,33716,667
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseD80.35120,0009,642,0000
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseD40.74148,0006,029,5200
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseD40.32128,0005,160,9600
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseD23.00136,0523,129,1960
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseD1.7022,51238,2700
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellD0.0072,0000072 K to 0 (-100.00 %)
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellD0.001,031072,00073 K to 72 K (-1.41 %)
Jun 23 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellD0.0028600286 to 0 (-100.00 %)
Jun 09 2015GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOGrantA0.0072,000073,0311 K to 73 K (+6,983.51 %)

Page:   1